24/7 LIVE STAFF — Compassionate help, any time day or night
CALL NOW 1-888-ATTY-911
Blog |

Minnesota Defective Breast Mesh & Acellular Dermal Matrix Injury Attorneys: Attorney911 (The Manginello Law Firm, PLLC) Brings 27+ Years of Federal-Court Trial Experience to Mayo Clinic and Masonic Cancer Center Patients — Ralph Manginello and Lupe Peña (Former Insurance Defense Attorney With Fluent Spanish) Litigate Allergan BIOCELL Recalled Implants (MDL 2921, District of New Jersey, Judge Martinotti, Bellwether October 19, 2026), AlloDerm, Strattice and GalaFLEX P4HB Scaffolds — BIA-ALCL (CD30+/ALK-) and BIA-SCC Analyzed Under 21 CFR Parts 803, 807 and 814 — Riegel v. Medtronic Parallel-Claim Survivability Mapped for Minnesota Claimants Following 8th Circuit Authority — $50M+ Recovered for Families and Active $10M Bermudez v. Pi Kappa Phi Institutional-Liability Litigation — Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911

May 14, 2026 13 min read
minnesota-featured-image.png

Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Minnesota: The Complete Guide for Women, Families, and Survivors

For women across Minnesota—from the major medical corridors of Minneapolis and St. Paul to the world-renowned surgical centers in Rochester and the surrounding regional hubs—the decision to undergo breast reconstruction or elective augmentation is one rooted in hope, healing, and personal agency. Whether you are a breast cancer survivor navigating the aftermath of a mastectomy or a patient seeking a revision of a previous procedure, you placed your trust in a medical device industry that promised safety and innovation.

At The Manginello Law Firm, PLLC, operating under the consumer brand Attorney911, we have been listening to the stories of women whose hope was met with a catastrophic failure of that trust. We represent women throughout Minnesota who have suffered debilitating complications from acellular dermal matrix (ADM), bioabsorbable scaffolds like GalaFLEX, and synthetic mesh products that were never cleared by the FDA for use in breast surgery.

If you are experiencing chronic pain, persistent redness, fluid collections, or have received a diagnosis of a rare cancer like BIA-ALCL or BIA-SCC, you are not just a medical statistic. You are a Minnesota resident with specific legal rights under our state’s product liability framework. Ralph Manginello, with 27 years of continuous practice experience (Texas Bar #24007597), and Lupe Peña, an associate with deep insurance-defense insights, provide a technical and tactical advantage that generalist personal injury firms cannot match.

The path forward begins with understanding what happened to your body. This guide is designed to provide you and your family with the clinical, regulatory, and legal clarity you deserve. When you are ready to discuss your specific situation, we are here for a confidential, no-obligation consultation at 1-888-ATTY-911 (1-888-288-9911).

The Regulatory Failure: What Minnesota Patients Weren’t Told

Most patients in Minnesota believe that if a medical device is used in a high-profile hospital or a specialized plastic surgery clinic, it must have undergone rigorous human clinical trials for that specific use. Unfortunately, for surgical mesh and scaffolds used in the or “internal bra” technique, the opposite is true.

The 510(k) Clearinghouse vs. FDA Approval

The vast majority of acellular dermal matrices (ADMs) and bioabsorbable scaffolds used in Minnesota operating rooms entered the market through the FDA 510(k) clearance pathway. You must understand the legal distinction: clearance is not the same as approval.

Under 21 U.S.C. § 360c and 21 CFR Part 807, a device can be “cleared” if the manufacturer shows it is “substantially equivalent” to a previous “predicate” device. It does not require independent clinical trials for the new indication. For decades, manufacturers have used “predicate creep” to move devices from general soft-tissue reinforcement into the delicate environment of the breast without ever proving to the FDA that they were safe for breast cancer survivors or cosmetic patients.

The FDA finally addressed this head-on on November 9, 2023, in a letter to health care providers that every woman in Minnesota should read. The agency stated verbatim:

“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”

Furthermore, the FDA explicitly noted that “no surgical mesh products have been cleared or approved by the FDA for use in breast surgery.” Products like GalaFLEX, Phasix, AlloDerm, and Strattice were all used off-label for years before this warning was issued. If your surgeon in Minneapolis, Rochester, or Duluth used these products, they were often acting on marketing materials provided by companies like Becton Dickinson (BD), Allergan, and Integra LifeSciences—materials that may have minimized the known risks of these materials.

The “Internal Bra” and the Brand Universe

In Minnesota, many women undergo a mastopexy (breast lift) or reconstruction where a “scaffold” is used to provide support—often marketed as an “internal bra.” It is critical to identify the specific brand implanted in your body. We assist clients in Minnesota with securing their operative reports to find the Unique Device Identifier (UDI) or lot numbers for these products.

Acellular Dermal Matrices (ADM)

These are biological scaffolds derived from human or animal skin.

  • AlloDerm and AlloDerm RTU (Allergan/AbbVie)
  • Strattice (Porcine-derived)
  • FlexHD and FlexHD Pliable (MTF Biologics)
  • AlloMax (C.R. Bard/BD) – Specifically named by the FDA in March 2021 for higher rates of reoperation and infection.

Bioabsorbable Scaffolds

These are synthetic materials designed to be absorbed by the body over 12 to 24 months.

  • GalaFLEX (Scaffold, 3D, 3DR, Lite): Composed of poly-4-hydroxybutyrate (P4HB).
  • Phasix Mesh: Also P4HB, originally cleared for hernia repair.
  • DuraSorb: A monofilament mesh made of polydioxanone (PDO).

At Attorney911, we investigate how these materials interact with human tissue. For example, P4HB (GalaFLEX) is supposed to resorbe naturally, but many reports in the FDA’s MAUDE database show these scaffolds causing chronic inflammation or failing to resorbe as promised, leading to a palpable, painful “plastic” feeling in the breast years after the procedure.

Recognizing the Complications: Serious Injuries and Latent Dangers

Complications from these devices can range from immediate surgical failures to cancers that develop years after the initial surgery. If you reside in Minnesota and are experiencing any of the following, you should seek medical evaluation and legal counsel immediately.

BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma

This is not breast cancer; it is a type of non-Hodgkin lymphoma that develops in the scar tissue (capsule) around the implant. Since 2016, the World Health Organization has recognized BIA-ALCL as a distinct malignancy.

  • Pathology: CD30 positive, ALK negative.
  • Presentation: Typically presents as a “late seroma”—a sudden swelling or fluid collection occurring 7 to 10 years after surgery.
  • Recall: The Allergan BIOCELL textured implants were subject to a worldwide recall in July 2019 due to their overwhelming association with this cancer. Allergan BIOCELL MDL 2921 is currently ongoing in the District of New Jersey, with a bellwether trial set for October 19, 2026.

BIA-SCC: Breast Implant-Associated Squamous Cell Carcinoma

An even rarer but often more aggressive cancer found in the implant capsule. The FDA issued an updated safety communication in March 2023 regarding BIA-SCC, noting that it has been found in both textured and smooth implants.

Red Breast Syndrome (RBS) and Endotoxin Science

Red Breast Syndrome is a non-infectious, sterile inflammation specific to ADM (like AlloDerm or FlexHD). Unlike a standard infection, RBS does not respond to antibiotics. Peer-reviewed literature suggests an endotoxin-mediated mechanism—bacterial components (LPS) that survive sterilization and trigger a chronic immune response in the Minnesota patient.

Reconstruction Failure and Disfigurement

  • Skin-flap necrosis: The death of the tissue overlying the reconstruction.
  • Mesh extrusion: The mesh or scaffold literally poking through the skin.
  • Capsular Contracture: Painful hardening of the breast (Baker Grade III/IV).
  • Sepsis: A life-threatening systemic infection that can lead to organ failure or death.

If you have suffered through multiple revision surgeries near Minneapolis, St. Paul, or the Mayo Clinic system, Ralph Manginello and the team at Attorney911 have the substantive command of the medical literature to prove your case. We understand the “Bradford Hill” causation criteria required to link your device to your specific pathology.

Minnesota Legal Framework: Statutes and Deadlines

Navigating a medical device lawsuit in Minnesota requires a firm that knows our state’s specific rules. Unlike general personal injury, device litigation is governed by strict statutes of limitation and repose.

The 4-Year Statute of Limitations

In Minnesota, the statute of limitations for personal injury is generally four years from the date the injury occurred or was discovered. However, medical device cases often involve the “Discovery Rule.” For many Minnesota women, the “discovery” of the link between their device and their injury didn’t happen until the FDA’s 2023 labeling update or a specific diagnosis of BIA-ALCL.

The 10-Year Statute of Repose

Minnesota also has a Statute of Repose (Minn. Stat. § 541.051), which can act as an absolute bar to a lawsuit ten years after the product was first sold, regardless of when the injury was discovered. This makes it imperative that you contact Attorney911 as soon as you suspect a problem.

Comparative Fault in Minnesota

Minnesota follows a “modified comparative fault” rule. This means a plaintiff can recover damages as long as their fault is not greater than the combined fault of the defendants. In the context of defective mesh, the “fault” almost never lies with the patient, but the defense will often try to blame the surgeon as a “learned intermediary.”

We counter this defense by showing that the manufacturers—like Becton Dickinson or Allergan—bypassed the surgeon’s judgment through misleading off-label marketing. Lupe Peña, with her experience in insurance defense, knows exactly how these carriers try to point the finger elsewhere to avoid paying the claims they owe.

Why Specialized Legal Representation Matters in Minnesota

There are thousands of personal injury lawyers in Minnesota, but few have a practice dedicated to the intersection of 21 CFR regulations, mass tort coordinated proceedings, and high-stakes medical litigation.

The Attorney911 Advantage

  • National Capability, Local Focus: While we serve the entire state of Minnesota, our firm’s lead counsel, Ralph Manginello, is admitted to the United States District Court for the Southern District of Texas and has been a member of the State Bar of Texas for over 27 years. We have the structural power to prosecute multi-defendant institutional liability.
  • Active High-Profile Litigation: We are currently lead counsel of record in Bermudez v. Pi Kappa Phi, seeking $10,000,000 in damages against thirteen defendants including major educational institutions. This is the level of litigation capacity we bring to every defective device case.
  • Bilingual Representation: Lupe Peña conducts full client consultations in fluent Spanish. This is essential for Minnesota’s diverse communities who deserve direct attorney communication without the barrier of an interpreter.
  • Expert Network: We work with world-class pathologists, oncologists, and plastic surgeons to secure pathology slides, review imaging, and build a case that can survive a Daubert challenge in Minnesota federal courts.

Our firm holds an 8.2 “Excellent” Avvo Rating and a Martindale-Hubbell Preeminent rating. We have recovered over $50 million for our clients because we don’t just file cases—we litigate them to their full potential.

Frequently Asked Questions for Minnesota Patients

1. Is surgical mesh approved for breast surgery?

No. As of the current date, no surgical mesh, ADM, or scaffold product has been approved by the FDA for use in breast reconstruction or augmentation. They are “cleared” for general tissue reinforcement, and their use in breasts is considered “off-label.”

2. Can I sue if I am not diagnosed with cancer?

Yes. Many of our Minnesota clients suffer from reconstruction failure, chronic pain, and permanent disfigurement. You do not need a cancer diagnosis to file a product liability claim if the device was defectively designed or the manufacturer failed to warn about known complications like Red Breast Syndrome or chronic inflammation.

3. How do I know which brand was used?

You must request your complete operative report and implant log from the hospital where your surgery was performed. These records belong to you by law. We can assist you in navigating this process if the hospital is being obstructive.

4. What is the “learned intermediary” doctrine?

This is a legal defense where the manufacturer argues they gave all the necessary warnings to your surgeon, not you. We fight this by proving the manufacturer engaged in off-label promotion and withheld critical safety data, which compromises the surgeon’s ability to act as a truly informed “intermediary.”

5. What does the GalaFLEX whistleblower say?

Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director at BD, was terminated after raising safety concerns. He alleges that BD withheld data on breast cancer recurrences in GalaFLEX trials and failed to properly report adverse events to the FDA’s MAUDE database. His testimony is a cornerstone of the case against BD/Galatea.

6. Do I have to pay upfront to start a case?

Absolutely not. Attorney911 operates on a contingency fee basis. We cover all the costs of the investigation, the experts, and the filing. We only get paid if we recover compensation for you.

Taking Action: Your Path to Recovery in Minnesota

If you are a resident of Minnesota and believe your breast mesh or scaffold has failed, the most important step is to preserve the evidence. If you are undergoing a revision or explant surgery, ensure your counsel knows so we can issue a “preservation letter” to the pathology lab to prevent the destruction of the materials removed from your body.

Your well-being is the only priority that matters. Regardless of whether you are ready to file a lawsuit today, you deserve answers about what happened to your health. We invite you to call us at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation.

You may also reach us online at attorney911.com. We are the firm that stands against institutional negligence, from the halls of fraternity houses to the boardrooms of multi-billion dollar medical device manufacturers. If you speak Spanish, ask for Lupe Peñahablamos español.

Minnesota survivors, the law is here to protect you, but you must take the first step. Let us help you find the justice and compensation you need to rebuild your life.

Disclaimers:
This content is provided for educational and informational purposes only and does not constitute legal advice. Past results do not guarantee future outcomes. No attorney-client relationship is formed until a written representation agreement is signed by both the client and the firm. The Manginello Law Firm, PLLC is a Texas-based firm. For cases outside Texas, we may work with local counsel in Minnesota or seek admission pro hac vice to handle your case.

Share this article:

Need Legal Help?

Free consultation. No fee unless we win your case.

Call 1-888-ATTY-911

Ready to Fight for Your Rights?

Free consultation. No upfront costs. We don't get paid unless we win your case.

Call 1-888-ATTY-911